🍽️ low processed foods diet

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of low processed foods diet On Probiotics

Rank Probiotic Impact
species Akkermansia muciniphila Increases

Bacteria Impacted by low processed foods diet

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Ruminococcaceae family Increases 📓 Source Study
Verrucomicrobiaceae family Increases 📓 Source Study
Acetanaerobacterium genus Decreases 👶 Source Study
Acetivibrio genus Decreases 👶 Source Study
Agathobaculum genus Decreases 👶 Source Study
Anaerofilum genus Decreases 👶 Source Study
Anaeromassilibacillus genus Decreases 👶 Source Study
Anaerotruncus genus Decreases 👶 Source Study
Angelakisella genus Decreases 👶 Source Study
Bittarella (ex Durand et al. 2017) genus Decreases 👶 Source Study
Candidatus Soleaferrea genus Decreases 👶 Source Study
Caproiciproducens genus Decreases 👶 Source Study
Ethanoligenens genus Decreases 👶 Source Study
Flavonifractor genus Decreases 👶 Source Study
Fournierella genus Decreases 👶 Source Study
Gemmiger genus Decreases 👶 Source Study BMI, fat percent,blood pressure
Gorbachella genus Decreases 👶 Source Study
Hydrogenoanaerobacterium genus Decreases 👶 Source Study
Neglectibacter genus Decreases 👶 Source Study
Oscillospira genus Decreases 👶 Source Study
Papillibacter genus Decreases 👶 Source Study
Pseudoflavonifractor genus Decreases 👶 Source Study
Ruminococcus genus Decreases 👶 Source Study
Ruthenibacterium genus Decreases 👶 Source Study
Sporobacter genus Decreases 👶 Source Study
Subdoligranulum genus Decreases 👶 Source Study
Acutalibacter genus Decreases 👶 Source Study
Drancourtella genus Decreases 👶 Source Study
Harryflintia genus Decreases 👶 Source Study
Neobittarella genus Decreases 👶 Source Study
Provencibacterium genus Decreases 👶 Source Study
Brevifollis genus Increases 👶 Source Study
Fucophilus genus Increases 👶 Source Study
Haloferula genus Increases 👶 Source Study
Luteolibacter genus Increases 👶 Source Study
Massilimalia genus Increases 👶 Source Study
Persicirhabdus genus Increases 👶 Source Study
Prosthecobacter genus Increases 👶 Source Study
Roseimicrobium genus Increases 👶 Source Study
Sulfuriroseicoccus genus Increases 👶 Source Study
Verrucomicrobium genus Increases 👶 Source Study
Negativibacillus genus Increases 👶 Source Study
Phocea genus Increases 👶 Source Study
Akkermansia genus Increases 📓 Source Study
Faecalibacterium genus Increases 📓 Source Study
Oscillospiraceae incertae sedis no rank Decreases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
unclassified Akkermansia no rank Increases 👶 Source Study
unclassified Faecalibacterium no rank Increases 👶 Source Study
environmental samples norank Increases 👶 Source Study
Pseudoflavonifractor capillosus species Increases ⚗️ Source Study
Akkermansia glycaniphila species Increases 👶 Source Study
Akkermansia muciniphila species Increases 👶 Source Study
Akkermansia sp. species Increases 👶 Source Study
Faecalibacterium duncaniae species Increases 👶 Source Study
Faecalibacterium hominis (ex Afrizal et al. 2022) species Increases 👶 Source Study
Faecalibacterium longum species Increases 👶 Source Study
Faecalibacterium prausnitzii species Increases 👶 Source Study
Faecalibacterium sp. An122 species Increases 👶 Source Study
Faecalibacterium sp. OF04-11AC species Increases 👶 Source Study
Faecalibacterium sp. OM04-11BH species Increases 👶 Source Study
Faecalibacterium sp. species Increases 👶 Source Study
Akkermansia muciniphila species Increases 📓 Source Study
Faecalibacterium prausnitzii species Increases 📓 Source Study
Faecalibacterium sp. canine oral taxon 147 species Increases 📓 Source Study
Faecalibacterium sp. DJF_VR20 species Increases 📓 Source Study
Akkermansia muciniphila ATCC BAA-835 strain Increases 👶 Source Study
Faecalibacterium cf. prausnitzii KLE1255 strain Increases 👶 Source Study
Faecalibacterium prausnitzii L2-6 strain Increases 👶 Source Study
Faecalibacterium prausnitzii M21/2 strain Increases 👶 Source Study
Faecalibacterium prausnitzii SL3/3 strain Increases 👶 Source Study
Chlamydiae/Verrucomicrobia group superphylum Increases ⚗️ Source Study

Impact of low processed foods diet on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.2 -0.2
Acne 0.6 0.6
ADHD 1.4 0.5 1.8
Allergic Rhinitis (Hay Fever) 0.6 -0.6
Allergies 0.8 1.2 -0.5
Allergy to milk products 0.5 0.6 -0.2
Alzheimer's disease 1.9 2.3 -0.21
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.1 1.8 -0.64
Ankylosing spondylitis 0.8 -0.8
Anorexia Nervosa 1.2 0.8 0.5
Asthma 2.6 0.4 5.5
Atherosclerosis 1.4 0.6 1.33
Atrial fibrillation 0.8 0.8
Autism 3.1 2.9 0.07
Bipolar Disorder 1.7 2.1 -0.24
Brain Trauma 1 1
Breast Cancer 0.2 -0.2
Carcinoma 0.5 0.7 -0.4
Celiac Disease 1.8 1 0.8
Cerebral Palsy 0.6 0.8 -0.33
Chronic Fatigue Syndrome 1.5 0.1 14
Chronic Kidney Disease 0.8 0.2 3
Chronic Obstructive Pulmonary Disease (COPD) 0.2 0.2
Chronic Urticaria (Hives) 1.4 1.4
Coagulation / Micro clot triggering bacteria 0.5 -0.5
Colorectal Cancer 0.8 0.8
Constipation 0.6 0.6
Coronary artery disease 0.2 0.5 -1.5
COVID-19 3.1 1.2 1.58
Crohn's Disease 3.4 2.8 0.21
cystic fibrosis 0.6 0.6
deep vein thrombosis 0.5 -0.5
Depression 3.2 1.7 0.88
Eczema 1 -1
Endometriosis 0.2 1.2 -5
Epilepsy 1.8 2 -0.11
Fibromyalgia 1.2 0.6 1
Functional constipation / chronic idiopathic constipation 1.1 1.2 -0.09
gallstone disease (gsd) 1.3 1.3
Glioblastoma 0.6 0.6
Gout 0.6 0.6
Hashimoto's thyroiditis 0.8 0.6 0.33
hypercholesterolemia (High Cholesterol) 1 1
hyperglycemia 1.4 0.6 1.33
Hyperlipidemia (High Blood Fats) 1.2 -1.2
hypersomnia 0.5 0.5
hypertension (High Blood Pressure 2 1.2 0.67
Hypothyroidism 0.8 0.2 3
Hypoxia 0.6 -0.6
IgA nephropathy (IgAN) 0.8 -0.8
Inflammatory Bowel Disease 2.2 1.1 1
Insomnia 0.6 0.6
Intelligence 0.6 0.2 2
Intracranial aneurysms 1.6 1.6
Irritable Bowel Syndrome 1.6 1.5 0.07
Liver Cirrhosis 1.7 1.7 0
Long COVID 3.3 3.1 0.06
Low bone mineral density 0.2 -0.2
Lung Cancer 1 0.2 4
ME/CFS with IBS 1 1
ME/CFS without IBS 0.2 0.1 1
Metabolic Syndrome 4.6 1.9 1.42
Mood Disorders 3.6 3.1 0.16
multiple chemical sensitivity [MCS] 0.4 0.6 -0.5
Multiple Sclerosis 2.3 2.1 0.1
Multiple system atrophy (MSA) 1.2 -1.2
Neuropathy (all types) 0.6 -0.6
neuropsychiatric disorders (PANDAS, PANS) 1.2 1.2
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 2 1.1 0.82
Obesity 4 2.8 0.43
obsessive-compulsive disorder 1.8 0.8 1.25
Osteoarthritis 1 0.5 1
Osteoporosis 1.2 0.8 0.5
Parkinson's Disease 2.1 2.4 -0.14
Polycystic ovary syndrome 1.4 0.4 2.5
Psoriasis 0.6 1.2 -1
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.7 1.2 0.42
Rosacea 0.2 0.2
Schizophrenia 1.3 1.2 0.08
scoliosis 0.2 -0.2
Sjögren syndrome 1.6 1.2 0.33
Sleep Apnea 1.1 1.1
Stress / posttraumatic stress disorder 2 0.8 1.5
Systemic Lupus Erythematosus 1.4 0.5 1.8
Tic Disorder 0.2 0.6 -2
Tourette syndrome 0.6 -0.6
Type 1 Diabetes 1.4 1.4
Type 2 Diabetes 4 1.9 1.11
Ulcerative colitis 3.3 0.8 3.12
Unhealthy Ageing 1.2 0.2 5

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)